Performance of the Breast Cancer Index versus Onco<em>type</em> DX Recurrence Score and IHC4 in Predicting Late Recurrence of Breast Cancer


Performance of the Breast Cancer Index versus Oncotype DX Recurrence Score and IHC4 in Predicting Late Recurrence of Breast Cancer
Slides from a presentation at SABCS 2012 and transcribed comments from a recent interview with Lisa A Carey, MD (1/17/13)

Sgroi DC et al. Comparative performance of Breast Cancer Index (BCI) vs Oncotype Dx and IHC4 in the prediction of late recurrence in HR-positive, LN-negative breast cancer patients: A TransATAC study. San Antonio Breast Cancer Symposium 2012;Abstract S1-9.

Dr Carey is Richardson and Marilyn Jacobs Preyer Distinguished Professor for Breast Cancer Research, Chief of the Division of Hematology and Oncology, Physician-in-Chief at the North Carolina Cancer Hospital and Associate Director for Clinical Research at the Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina.